322 related articles for article (PubMed ID: 22462566)
21. Location of residual cancer after transrectal high-intensity focused ultrasound ablation for clinically localized prostate cancer.
Boutier R; Girouin N; Cheikh AB; Belot A; Rabilloud M; Gelet A; Chapelon JY; Rouvière O
BJU Int; 2011 Dec; 108(11):1776-81. PubMed ID: 21711432
[TBL] [Abstract][Full Text] [Related]
22. The utility of transrectal real-time elastography in the diagnosis of prostate cancer.
Kamoi K; Okihara K; Ochiai A; Ukimura O; Mizutani Y; Kawauchi A; Miki T
Ultrasound Med Biol; 2008 Jul; 34(7):1025-32. PubMed ID: 18255215
[TBL] [Abstract][Full Text] [Related]
23. Transrectal ultrasound and core biopsies for the diagnosis of prostate cancer. A study of pretreatment investigation strategy for patients with suspected prostate cancer.
Norberg M
Acta Radiol Suppl; 1994; 393():1-21. PubMed ID: 8184698
[TBL] [Abstract][Full Text] [Related]
24. The value and limitations of contrast-enhanced transrectal ultrasonography for the detection of prostate cancer.
Zhao HX; Xia CX; Yin HX; Guo N; Zhu Q
Eur J Radiol; 2013 Nov; 82(11):e641-7. PubMed ID: 23916578
[TBL] [Abstract][Full Text] [Related]
25. Outcomes of transrectal ultrasound scan of the prostate with sector biopsies for 323 New Zealand men with suspicion of prostate cancer.
Smart R
N Z Med J; 1999 Dec; 112(1101):465-9. PubMed ID: 10678211
[TBL] [Abstract][Full Text] [Related]
26. Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy.
Gallina A; Maccagnano C; Suardi N; Capitanio U; Abdollah F; Raber M; Salonia A; Scattoni V; Rigatti P; Montorsi F; Briganti A
BJU Int; 2012 Jul; 110(2 Pt 2):E64-8. PubMed ID: 22093108
[TBL] [Abstract][Full Text] [Related]
27. Staging of prostate cancer. Accuracy of transrectal ultrasound enhanced by prostate-specific antigen.
Wolf JS; Shinohara K; Narayan P
Br J Urol; 1992 Nov; 70(5):534-41. PubMed ID: 1281724
[TBL] [Abstract][Full Text] [Related]
28. The contribution of strain patterns in characterization of prostate peripheral zone lesions at transrectal ultrasonography.
Zhang Y; Tang J; Li YM; Fei X; He EH; Li QY; Shi HY
Acta Radiol; 2012 Feb; 53(1):119-26. PubMed ID: 22139716
[TBL] [Abstract][Full Text] [Related]
29. Status of transrectal ultrasound imaging of the prostate.
Aigner F; Mitterberger M; Rehder P; Pallwein L; Junker D; Horninger W; Frauscher F
J Endourol; 2010 May; 24(5):685-91. PubMed ID: 20433367
[TBL] [Abstract][Full Text] [Related]
30. [Efficacy of transrectal ultrasonography in staging prostate cancer].
Soh S; Egawa S
Nihon Rinsho; 1998 Aug; 56(8):2036-41. PubMed ID: 9750503
[TBL] [Abstract][Full Text] [Related]
31. Detection, localisation and characterisation of prostate cancer by prostate HistoScanning(™).
Simmons LA; Autier P; Zát'ura F; Braeckman J; Peltier A; Romic I; Stenzl A; Treurnicht K; Walker T; Nir D; Moore CM; Emberton M
BJU Int; 2012 Jul; 110(1):28-35. PubMed ID: 22093966
[TBL] [Abstract][Full Text] [Related]
32. Transrectal ultrasound and prostate biopsy clinic.
Wareing M
Nurs Stand; 2004 Feb 25-Mar 2; 18(24):33-7. PubMed ID: 15027239
[TBL] [Abstract][Full Text] [Related]
33. Supporting prostate cancer focal therapy: a multidisciplinary International Consensus of Experts ("ICE").
Reis LO; Billis A; Zequi SC; Tobias-Machado M; Viana P; Cerqueira M; Ward JF
Aging Male; 2014 Jun; 17(2):66-71. PubMed ID: 24597940
[TBL] [Abstract][Full Text] [Related]
34. Focal therapy of prostate cancer: making steady progress toward a first-line image-guided treatment modality.
Polascik TJ
Curr Opin Urol; 2015 May; 25(3):183-4. PubMed ID: 25775366
[No Abstract] [Full Text] [Related]
35. Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer.
Kuru TH; Roethke MC; Seidenader J; Simpfendörfer T; Boxler S; Alammar K; Rieker P; Popeneciu VI; Roth W; Pahernik S; Schlemmer HP; Hohenfellner M; Hadaschik BA
J Urol; 2013 Oct; 190(4):1380-6. PubMed ID: 23608676
[TBL] [Abstract][Full Text] [Related]
36. Transatlantic Consensus Group on active surveillance and focal therapy for prostate cancer.
Ahmed HU; Akin O; Coleman JA; Crane S; Emberton M; Goldenberg L; Hricak H; Kattan MW; Kurhanewicz J; Moore CM; Parker C; Polascik TJ; Scardino P; van As N; Villers A;
BJU Int; 2012 Jun; 109(11):1636-47. PubMed ID: 22077593
[TBL] [Abstract][Full Text] [Related]
37. Comparison of prostate volume measured by transrectal ultrasound and magnetic resonance imaging: is transrectal ultrasound suitable to determine which patients should undergo active surveillance?
Weiss BE; Wein AJ; Malkowicz SB; Guzzo TJ
Urol Oncol; 2013 Nov; 31(8):1436-40. PubMed ID: 22503576
[TBL] [Abstract][Full Text] [Related]
38. Contrast-enhanced transrectal ultrasound (CE-TRUS) with cadence-contrast pulse sequence (CPS) technology for the identification of prostate cancer.
Seitz M; Gratzke C; Schlenker B; Buchner A; Karl A; Roosen A; Singer BB; Bastian PJ; Ergün S; Stief CG; Reich O; Tilki D
Urol Oncol; 2011; 29(3):295-301. PubMed ID: 19523857
[TBL] [Abstract][Full Text] [Related]
39. Imaging techniques for prostate cancer: implications for focal therapy.
Turkbey B; Pinto PA; Choyke PL
Nat Rev Urol; 2009 Apr; 6(4):191-203. PubMed ID: 19352394
[TBL] [Abstract][Full Text] [Related]
40. Evolution and outcomes of 3 MHz high intensity focused ultrasound therapy for localized prostate cancer during 15 years.
Thüroff S; Chaussy C
J Urol; 2013 Aug; 190(2):702-10. PubMed ID: 23415962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
